1
|
P PMM, Degli Antoni M, Formenti B, Viola F, Castelli F, Amadasi S, Quiros-Roldan E. Characteristics of the population with mild COVID-19 symptoms eligible for early treatment attended in a single center in Northern Italy. J Infect Public Health 2022; 16:104-106. [PMCID: PMC9724552 DOI: 10.1016/j.jiph.2022.11.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2022] [Revised: 11/08/2022] [Accepted: 11/20/2022] [Indexed: 12/12/2022] Open
Abstract
After more than two years from the first COVID-19 detected case in Brescia, Northern Italy, monoclonal antibodies and antiviral therapy aimed at early treatment of mild COVID-19 in patients at risk of progression and of hospitalization has been approved in Italy. Here we report the characteristics of the population eligible for the COVID-19 early treatments at our COVID-19 Early Therapy Unit of the Infectious Diseases Department of the ASST Spedali Civili of Brescia, with the aim to evaluate the characteristics of the foreign and native groups. Up to March the 31st, 2022, a total of 559 patients were referred to our Unit for COVID-19 early treatment, where 7.6% were foreigners, a group significantly younger than natives (p<0.05). Particular differences are noticed between the native and the foreign population, where people aged > 65 years old were significantly more frequent among italians (39.7% vs 16.3%, p<0.01), while primary or acquired immunodeficiencies were more frequent in foreigners (55.8% vs 38.9%, p=0.03). Substantial differences are noted between native and foreign populations, where 14% and 26% (p<0.05) respectively have never been vaccinated for COVID-19. Overall, 71% of the referred patients received an early treatment for mild COVID-19, with no differences between the two groups. Overall, on day 28 after treatment, 23 (4%) patients had been hospitalized due to COVID-19 related complications and four died (0,7%), no one was foreigner. In conclusion, while the treatment offered for mild COVID-19 appears to be rather uniform between the native and the foreign populations, some differences, especially in preventive vaccination COVID-19, must be taken into account.
Collapse
Affiliation(s)
- Paola Magro Magro P
- U.O. Malattie Infettive, ASST Spedali Civili di Brescia e Università degli Studi di Brescia,Corresponding author
| | - M Degli Antoni
- U.O. Malattie Infettive, ASST Spedali Civili di Brescia e Università degli Studi di Brescia
| | - B Formenti
- Cattedra UNESCO “Formazione e rinforzo delle risorse umane per lo sviluppo sanitario nei Paesi a risorse limitate”, Università degli Studi di Brescia, Italia
| | - F Viola
- U.O. Malattie Infettive, ASST Spedali Civili di Brescia e Università degli Studi di Brescia
| | - F Castelli
- U.O. Malattie Infettive, ASST Spedali Civili di Brescia e Università degli Studi di Brescia,Cattedra UNESCO “Formazione e rinforzo delle risorse umane per lo sviluppo sanitario nei Paesi a risorse limitate”, Università degli Studi di Brescia, Italia
| | - S Amadasi
- U.O. Malattie Infettive, ASST Spedali Civili di Brescia e Università degli Studi di Brescia
| | - E Quiros-Roldan
- U.O. Malattie Infettive, ASST Spedali Civili di Brescia e Università degli Studi di Brescia
| |
Collapse
|
2
|
Marchese V, Formenti B, Marchese L, Gregori N, Gardini G, Russo G, Bona F, Di Rosario G, Gulletta M, Tomasoni LR, Castelli F, Matteelli A. COVID-19 effect on TB presentation and outcome. Int J Tuberc Lung Dis 2022; 26:375-377. [PMID: 35351245 DOI: 10.5588/ijtld.22.0036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
- V Marchese
- Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy, WHO Collaborating Center for TB/HIV Co-infection and the TB Elimination Strategy, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - B Formenti
- Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - L Marchese
- Institute for Particle Physics And Astrophysics, Eidgenössische Technische Hochschule Zürich, Zurich, Switzerland
| | - N Gregori
- Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy
| | - G Gardini
- Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy
| | - G Russo
- Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy, WHO Collaborating Center for TB/HIV Co-infection and the TB Elimination Strategy, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - F Bona
- Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy
| | - G Di Rosario
- Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy
| | - M Gulletta
- Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy
| | - L R Tomasoni
- Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy
| | - F Castelli
- Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy, WHO Collaborating Center for TB/HIV Co-infection and the TB Elimination Strategy, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - A Matteelli
- Department of Infectious and Tropical Diseases, Azienda Socio Sanitaria Territoriale Spedali Civili of Brescia and University of Brescia, Brescia, Italy, WHO Collaborating Center for TB/HIV Co-infection and the TB Elimination Strategy, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| |
Collapse
|
3
|
Casco N, Jorge AL, Palmero D, Alffenaar JW, Fox G, Ezz W, Cho JG, Skrahina A, Solodovnikova V, Bachez P, Arbex MA, Galvão T, Rabahi M, Pereira GR, Sales R, Silva DR, Saffie MM, Miranda RC, Cancino V, Carbonell M, Cisterna C, Concha C, Cruz A, Salinas NE, Revillot ME, Farias J, Fernandez I, Flores X, Gallegos P, Garavagno A, Guajardo C, Bahamondes MH, Merino LM, Muñoz E, Muñoz C, Navarro I, Navarro J, Ortega C, Palma S, Pardenas AM, Pereira G, Castillo PP, Pinto M, Pizarro R, Rivas F, Rodriguez P, Sánchez C, Serrano A, Soto A, Taiba C, Venegas M, Vergara MS, Vilca E, Villalon C, Yucra E, Li Y, Cruz A, Guelvez B, Plaza R, Tello K, Andréjak C, Blanc FX, Dourmane S, Froissart A, Izadifar A, Rivière F, Schlemmer F, Gupta N, Ish P, Mishra G, Sharma S, Singla R, Udwadia ZF, Manika K, Diallo BD, Hassane-Harouna S, Artiles N, Mejia LA, Alladio F, Calcagno A, Centis R, Codecasa LR, D Ambrosio L, Formenti B, Gaviraghi A, Giacomet V, Goletti D, Gualano G, Kuksa L, Danila E, Diktanas S, Miliauskas S, Ridaura RL, López F, Torrico MM, Rendon A, Akkerman OW, Piubello A, Souleymane MB, Aizpurua E, Gonzales R, Jurado J, Loban A, Aguirre S, de Egea V, Irala S, Medina A, Sequera G, Sosa N, Vázquez F, Manga S, Villanueva R, Araujo D, Duarte R, Marques TS, Grecu VI, Socaci A, Barkanova O, Bogorodskaya M, Borisov S, Mariandyshev A, Kaluzhenina A, Stosic M, Beh D, Ng D, Ong C, Solovic I, Dheda D, Gina P, Caminero JA, Cardoso-Landivar J, de Souza Galvão ML, Dominguez-Castellano A, García-García JM, Pinargote IM, Fernandez SQ, Sánchez-Montalvá A, Huguet ET, Murguiondo MZ, Bruchfeld J, Bart PA, Mazza-Stalder J, Tiberi S, Arrieta F, Heysell S, Logsdon J, Young L. TB and COVID-19 co-infection: rationale and aims of a global study. Int J Tuberc Lung Dis 2021; 25:78-80. [PMID: 33384052 DOI: 10.5588/ijtld.20.0786] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
| | | | | | | | - G Fox
- New South Wales, Australia
| | - W Ezz
- New South Wales, Australia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|